Prescription RequiredTOFACITINIB 5 mg (Tofajak) is a prescription medicine used to treat rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and certain cases of juvenile idiopathic arthritis. It belongs to a class of medicines called Janus kinase (JAK) inhibitors and works by reducing inflammation caused by an overactive immune system. It should be used only under the supervision of a healthcare professional.
| Generic name | TOFACITINIB |
| Strength | 5 mg |
| Manufacturer | Cipla |
| Package size | 60 Tablets |
| Used for | Rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Tofacitinib 5 mg works by blocking Janus kinase enzymes, which are involved in signalling pathways that trigger inflammation. By inhibiting these enzymes, it reduces the immune system’s overactive response and helps relieve pain, swelling, and inflammation associated with autoimmune conditions.
